Status:
COMPLETED
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
Lead Sponsor:
Kyoto University
Conditions:
Hepatitis B
Eligibility:
All Genders
18+ years
Brief Summary
Individuals with resolved hepatitis B, characterized as hepatitis B surface antigen (HBsAg)-negative and hepatitis B core antibody-positive, have latent hepatitis B virus (HBV) infection in their live...
Eligibility Criteria
Inclusion
- HBsAg-negative but anti-HBc-positive
Exclusion
- Serum HBV DNA-negative
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00881036
Start Date
August 1 2006
End Date
July 1 2015
Last Update
September 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kyoto Univesity
Kyoto, Kyoto, Japan, 606-8507